Gary W. Pace

Dr. Gary W Pace has more than 40 years of experience in the development and commercialization of advanced life sciences and related technologies, spanning biotechnology, pharmaceuticals, medical devices, and food industries. He is a serial entrepreneur and has held senior positions in small- and large-scale life sciences ventures and companies in the USA, Canada, Europe, Australia and New Zealand. He has long-term board level experience with multi-billion and small cap companies with an in-depth knowledge of all aspects of technical operations, compensation and corporate governance. Currently, he is a Director of Pacira Pharmaceuticals (NASDAQ: PCRX), Simavita Ltd. (ASX: SVA), Antisense Therapeutics (ASX: ANP) and Invitrocue (ASX: IVQ) as well as several private companies.

Dr. Pace is an elected Fellow of the Australian Academy of Technological Sciences and Engineering, as well as author or co-author of over 70 research papers and patents. In 2003, Dr. Pace was awarded a Centenary Medal by the Australian Government for service to Australian society in research and development. Dr. Pace holds a Ph.D. from MIT, where he was a Fulbright Scholar.